Special Issue "Genomics and Epigenetics of Rare Tumors"
Deadline for manuscript submissions: 26 February 2022.
Interests: genomic medicine; functional genomics; tumor predisposition syndromes; molecular genetics; cancer therapy; sarcoma
2. Department of Molecular Genetics, Cochin Hospital, AP-HP, 75006 Paris, France
Interests: neurofibromatosis; cancer; molecular genetics; NGS; RAS-MAPK pathway
Special Issues and Collections in MDPI journals
Better approaches to diagnosing and treating rare cancers are urgently needed, because treatments for many rare cancers have not advanced at the same pace as treatments for more common cancers. Genomic medicine is transforming our understanding of cancer’s origins and complexity by providing detailed characterizations of cancer development in an individual. As well as advancing our understanding of what causes each person’s cancer, genomics is providing insights into how an individual’s cancer might progress, and its likely response to treatment. Genomic and epigenomic profiling of rare tumors and cancers—which collectively account for a significant proportion of cancer diagnoses—has the potential to improve a patient's diagnosis and treatment.
This Special Issue of the International Journal of Molecular Sciences is dedicated to the genomics and epigenetics of rare cancers, and welcomes reviews and original papers covering recent genomic and epigenomic research on rare tumor and cancers, including solid and hematological malignancies, pediatric cancers, and tumor predisposition syndromes; case reports highlighting genomic medicine approaches that can be utilized in several clinical scenarios may also be considered.
Dr. Camille Tlemsani
Dr. Eric Pasmant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Genomics and epigenomics
- Rare tumors and cancers
- Precision therapy
- Genomic medicine